<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29</volume><submitter>Hao Y</submitter><pubmed_abstract>Traumatic brain injury (TBI) can lead to severe neurotrauma, leading to long-term cognitive decline and even death. Massive neuronal loss and excessive neuroinflammation are critical issues in the treatment of secondary TBI. To tackle these challenges, we developed a GelMA and CSMA hydrogel loaded with Erythropoietin (EPO) and Interleukin-4 (IL-4), named GC/I/E. By directly loading the hydrogel with EPO, rapid neuroprotection and angiogenesis were achieved. Meanwhile, by loading Mesoporous silica nanoparticles (MSNs) with IL-4 (MSN@IL-4), sustained inflammation modulation during inflammation was attained. &lt;i>In vitro&lt;/i> experiments demonstrated that GC/I/E hydrogel were biocompatible and could provide neuroprotection for HT22 cells in H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> environment, regulate RAW26</pubmed_abstract><journal>Materials today. Bio</journal><pagination>101335</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11609671</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Bioactive hydrogel synergizes neuroprotection, macrophage polarization, and angiogenesis to improve repair of traumatic brain injury.</pubmed_title><pmcid>PMC11609671</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Feng L</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>He X</pubmed_authors><pubmed_authors>Hao Y</pubmed_authors><pubmed_authors>Guo R</pubmed_authors><pubmed_authors>Cheng H</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><pubmed_authors>Jin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bioactive hydrogel synergizes neuroprotection, macrophage polarization, and angiogenesis to improve repair of traumatic brain injury.</name><description>Traumatic brain injury (TBI) can lead to severe neurotrauma, leading to long-term cognitive decline and even death. Massive neuronal loss and excessive neuroinflammation are critical issues in the treatment of secondary TBI. To tackle these challenges, we developed a GelMA and CSMA hydrogel loaded with Erythropoietin (EPO) and Interleukin-4 (IL-4), named GC/I/E. By directly loading the hydrogel with EPO, rapid neuroprotection and angiogenesis were achieved. Meanwhile, by loading Mesoporous silica nanoparticles (MSNs) with IL-4 (MSN@IL-4), sustained inflammation modulation during inflammation was attained. &lt;i>In vitro&lt;/i> experiments demonstrated that GC/I/E hydrogel were biocompatible and could provide neuroprotection for HT22 cells in H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> environment, regulate RAW26</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T00:21:50.065Z</modification><creation>2025-04-04T00:21:50.065Z</creation></dates><accession>S-EPMC11609671</accession><cross_references><pubmed>39624047</pubmed><doi>10.1016/j.mtbio.2024.101335</doi></cross_references></HashMap>